SCHEMBL475083

SCHEMBL475083

O=C(O)CCC(=O)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL8428644 0.97 LMNA (0.60)
Methane SCHEMBL5760431 0.97
SCHEMBL15068126 0.97
Iodide SCHEMBL11881090 0.94 LMNA (0.56)
Levulinic Acid SCHEMBL18740348 0.86 LMNA (0.74)
Succinic Acid SCHEMBL27576266 0.85 LMNA (0.75)
Succinic Acid SCHEMBL27576268 0.85 LMNA (0.75)
SCHEMBL43375 0.84
Succinic Acid SCHEMBL27933835 0.81 LMNA (0.69)
SCHEMBL11414863 0.81

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 371 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9809822-B2 Triptolide derivatives and preparation method and use thereof HONG KONG BAPTIST UNIVERSITY (HK) 2017-11-07 US claimed
CN-107011203-A A kind of LCZ696 intermediate As HU 377 preparation method 江苏阿尔法药业有限公司 2017-08-04 CN claimed
US-7732625-B2 Colorant compounds XEROX CORPORATION (US) 2010-06-08 US claimed
US-7311767-B2 Forming a salt of a liquid phase change ink carrier of stearyl stearamide, an amine substituted Xanthene, acridine, anthracene or thioxanthene chromogen, and a metal salt capable of forming a compound with two chromogens XEROX CORPORATION (US) 2007-12-25 US claimed
US-7033424-B2 Phase change inks XEROX CORPORATION (US) 2006-04-25 US claimed
US-20060021546-A1 Processes for preparing phase change inks XEROX CORPORATION 2006-02-02 US claimed
US-20060020141-A1 Metallized dye XEROX CORPORATION 2006-01-26 US claimed
US-20060016369-A1 PHASE CHANGE INKS XEROX CORPORATION 2006-01-26 US claimed
US-RE36234-E Aspartic acid copolymers and their preparation DONLAR CORPORATION (US) 1999-06-22 US claimed
US-5736371-A ACYLATION OF POLY(OR OLIGO-)SACCHARIDE WITH A DICARBOXYLIC ACID MONOCHLORIDE, THEN GRINDING, DRYING AND COUPLING A FATTY ACID TO SURFACE LAYER WHICH IS THEN HYDROPHOBICALLY BONDED TO PHOSPHOLIPIDS, AS CARRIERS FOR DRUG DELIVERY A ET S BIOVECTEURS (FR) 1998-04-07 US claimed
EP-0542969-B1 BIODEGRADABLE PARTICULATE VECTOR AND METHOD OF SYNTHESIS BIOVECTOR THERAPEUTICS SA (FR) 1997-05-07 EP claimed
US-4281184-A REACTIC ACETIC ANHYDRIDE AND HYDROCHLORIC ACID FONDAZIONE DENORA (IT) 1981-07-28 US claimed
JP-63012341-A None JP disclosed
CN-122028974-A Ribonucleic acid-based microcapsules 弗门尼舍有限公司 2026-05-12 CN disclosed
EP-4735461-A2 ALKYLATED BODIPY COMPOUND AND METHODS OF USING THE ALKYLATED BODIPY COMPOUND Board of Regents, The University of Texas System (US) 2026-05-06 EP disclosed
EP-4332086-B1 COMPOUND OR SALT THEREOF, LIPID PARTICLES, AND PHARMACEUTICAL COMPOSITION FUJIFILM CORP (JP) 2026-04-08 EP disclosed
US-4276417-A TREATMENT OF VASCULAR-CONDITION HYPERTENSION HOFFMANN-LA ROCHE INC. (US) 1981-06-30 US disclosed
US-4044147-A N-(acyl)-p-amino-N'-(monosubstituted)-benzamide anti-ulcer agents PFIZER INC. (US) 1977-08-23 US disclosed
US-4008257-A 2,2-Dimethyl-2-[(7,15,16,17-tetrahydro-17,17-dimethyl-6H-cyclopenta[a]phenanthren-3-yl)oxy]ethyl alkanedioates and intermediates thereto G. D. SEARLE & CO. (US) 1977-02-15 US disclosed
US-3996270-A Intermediate for Gossyplure, the sex pheromone of the pink bollworm STORY CHEMICAL CORPORATION (US) 1976-12-07 US disclosed